Akero Therapeutics Inc buy Cantor Fitzgerald
Start price
12.06.24
/
50%
€23.57
Target price
12.06.25
-
Performance (%)
-8.02%
Price
21.06.24
€21.68
Summary
This prediction is currently active. With a performance of -8.02%, the BUY prediction for Akero Therapeutics Inc by Cantor_Fitzgerald is down slightly. This prediction currently runs until 12.06.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Akero Therapeutics Inc | 1.641% |
| iShares Core DAX® | 0.611% |
| iShares Nasdaq 100 | -0.208% |
| iShares Nikkei 225® | 1.298% |
| iShares S&P 500 | 0.636% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for AKRO provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
11.10.23
11.10.23
€36.75
11.10.24
11.10.24
57.10%
21.06.24
21.06.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
04.10.23
04.10.23
€65.81
04.10.24
04.10.24
-49.79%
21.06.24
21.06.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€48.20
19.09.23
19.09.23
€64.47
19.09.24
19.09.24
-54.59%
21.06.24
21.06.24